NYSEFinancialsBanks - DiversifiedSnapshot 2026-07-09
Reading HSBC? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in deceleration. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisModerate volatility — typically moves about 1% a day.
View RiskNot enough reads yet
HSBC's growth depends on its strong investment banking capabilities and product offerings. The recent gold clearing trial and senior hires in the Middle East support this claim. HSBC trades at a premium compared to its peers, which suggests high expectations. If the Fed cuts rates, HSBC's performance could weaken significantly. Peer multiples imply a price about 12% above where it trades; this read is provisional.
Trailing returns as of 2026-07-10. HSBC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 3 analysts currently covering HSBC (as of Jul 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-07-11. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus peers — fair value, gap to price, and forward P/E.
Gold price drop impacts macroeconomic outlook and HSBC's forecasts.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-10. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Weakening business optimism may impact HSBC's growth outlook.
Potential sale could improve risk profile and capital allocation.
Lower stock price target indicates reduced growth expectations.
Lower gold price forecasts reflect macroeconomic headwinds.
Halting high-risk credit impacts risk profile.
Gold clearing trial enhances HSBC's product offerings and market position.
Restricting loans aligns with risk management objectives.
